Explore how product hopping and REMS abuse block generic drug competition. Learn about key antitrust cases like NY v. Actavis, FTC enforcement actions, and the economic impact on healthcare costs.
Learn more...Discover how brand manufacturers produce authorized generics to retain market share after patents expire. Learn the production process, pricing strategies, and consumer impact.
Learn more...